Carcinoma, Pancreatic: Clinical Trials

6 trials for Carcinoma, Pancreatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 terminated, 1 withdrawn. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Not applicable1Terminated 1

Follow Carcinoma, Pancreatic: new trials by email Literature Review of Carcinoma, Pancreatic trials Research Report on Carcinoma, Pancreatic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Stage III Breast Cancer, Stage IV Breast Cancer
WithdrawnTravera Inc2024-11-012024-11-25
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Pleural Effusion, Malignant, Ascites, Malignant
CompletedTravera Inc722022-07-152026-04-13
MRI Only Radiation Therapy With CPAP
CPAP machine - Carcinoma Liver, Carcinoma, Pancreatic
Not applicableTerminatedAlbert Einstein College of Medicine52018-04-242024-01-18
Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer
Transcatheter arterial infusion, Intravenous chemotherapy, Gemcitabine - Carcinoma, Pancreatic
Phase 2UnknownFudan University1682015-12-012020-03-05
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
radiofrequency ablation, S-1 - Carcinoma, Pancreatic
Phase 2UnknownFudan University302013-10-012015-12-18
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
No intervention - Neuroendocrine Tumor of Pancreas, Carcinoma, Pancreatic
CompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine782012-01-012021-07-27

Narrower conditions

Pancreatic Neoplasms (6)  ·  Carcinoma, Hepatocellular (3)  ·  Anus Neoplasms (2)  ·  Appendiceal Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Carcinoma (2)  ·  Carcinoma, Neuroendocrine (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Cholangiocarcinoma (2)  ·  Esophageal Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Mesothelioma (2)  ·  Mouth Neoplasms (2)

Broader conditions

Digestive System Diseases (6)  ·  Digestive System Neoplasms (6)  ·  Endocrine Gland Neoplasms (6)  ·  Endocrine System Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Pancreatic Diseases (6)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Adenocarcinoma (3)  ·  Adenoma (3)  ·  Liver Diseases (3)  ·  Liver Neoplasms (3)  ·  Adnexal Diseases (2)  ·  Anus Diseases (2)

Interventions

Gemcitabine (1)  ·  Oxaliplatin (1)  ·  Radiofrequency Ablation (1)  ·  S 1 (combination) (1)

Sponsors

Fudan University (2)  ·  Travera Inc (2)  ·  Albert Einstein College of Medicine (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (3)  ·  United States (2)

Top investigators

Madhur Garg, MD (1)  ·  Mark Stevens, Ph.D. (1)  ·  Mark Stevens, Phd (1)  ·  Risheng Yu (1)  ·  Rob Kimmerling, Phd (1)  ·  Robert Kimmerling, Ph.D. (1)  ·  Zhiqiang Meng, MD, Ph D (1)

Results publications

PMID 39095759